Search research articles
Contact Us
Filters
Showing results (81-90 of 132) with videos related to
Page
of 14
Sort By:
Cytometry. Part B, Clinical Cytometry
|
August 15, 2025
Immunophenotypic, cytogenetic, and mutational features of chronic lymphocytic leukemia/small lymphocytic lymphoma with atypical immunophenotype
Wei J Wang, Sa A Wang, Hong Fang, et al.
Lung Cancer (Amsterdam, Netherlands)
|
May 19, 2015
Systemic and CNS activity of the RET inhibitor vandetanib combined with the mTOR inhibitor everolimus in KIF5B-RET re-arranged non-small cell lung cancer with brain metastases
Vivek Subbiah, Jenny Berry, Michael Roxas, et al.
Molecular Cytogenetics
|
August 25, 2015
Double inv(3)(q21q26.2) in acute myeloid leukemia is resulted from an acquired copy neutral loss of heterozygosity of chromosome 3q and associated with disease progression
Jun Gu, Keyur P Patel, Bing Bai, et al.
Leukemia Research
|
July 7, 2019
Clinical implications of cytogenetic heterogeneity in Philadelphia chromosome positive (Ph+) adult B cell acute lymphoblastic leukemia following tyrosine kinase inhibitors and chemotherapy regimens
Poonam Jain, Jun Gu, Rashmi Kanagal-Shamanna, et al.
Cancers
|
December 10, 2021
Integrated Clinical Genotype-Phenotype Characteristics of Blastic Plasmacytoid Dendritic Cell Neoplasm
C Cameron Yin, Naveen Pemmaraju, M James You, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
|
October 15, 2016
P53 expression correlates with poorer survival and augments the negative prognostic effect of MYC rearrangement, expression or concurrent MYC/BCL2 expression in diffuse large B-cell lymphoma
Xuan J Wang, L Jeffrey Medeiros, Carlos E Bueso-Ramos, et al.
American Journal of Clinical Pathology
|
May 27, 2024
Integrative immunophenotypic and genetic characterization of acute myeloid leukemia with CBFB rearrangement
Fnu Sameeta, Sa A Wang, Zhenya Tang, et al.
American Journal of Hematology
|
March 5, 2024
Myeloid neoplasm with <10% blasts and t(3;5)(q25.1;q34)/NPM::MLF1: A classification dilemma
Fnu Sameeta, Hong Fang, Wei Wang, et al.
Cancers
|
December 9, 2023
Cytogenetic Profile in Monoclonal Gammopathy of Undetermined Significance, Smoldering and Symptomatic Multiple Myeloma: A Study of 1087 Patients with Highly Purified Plasma Cells
Guilin Tang, Yilin Wu, Pei Lin, et al.
Journal of Neuropathology and Experimental Neurology
|
September 13, 2024
Epithelioid angiosarcoma arising from pleomorphic xanthoastrocytoma, CNS WHO grade 3
Austin J Helmink, Kanish Mirchia, Frank M Mezzacappa, et al.
Page
of 14
Search research articles
Search
Showing results (81-90 of 132) with videos related to
Sort By:
Page
of 14
Cytometry. Part B, Clinical Cytometry
|
August 15, 2025
Immunophenotypic, cytogenetic, and mutational features of chronic lymphocytic leukemia/small lymphocytic lymphoma with atypical immunophenotype
Wei J Wang, Sa A Wang, Hong Fang, et al.
Lung Cancer (Amsterdam, Netherlands)
|
May 19, 2015
Systemic and CNS activity of the RET inhibitor vandetanib combined with the mTOR inhibitor everolimus in KIF5B-RET re-arranged non-small cell lung cancer with brain metastases
Vivek Subbiah, Jenny Berry, Michael Roxas, et al.
Molecular Cytogenetics
|
August 25, 2015
Double inv(3)(q21q26.2) in acute myeloid leukemia is resulted from an acquired copy neutral loss of heterozygosity of chromosome 3q and associated with disease progression
Jun Gu, Keyur P Patel, Bing Bai, et al.
Leukemia Research
|
July 7, 2019
Clinical implications of cytogenetic heterogeneity in Philadelphia chromosome positive (Ph+) adult B cell acute lymphoblastic leukemia following tyrosine kinase inhibitors and chemotherapy regimens
Poonam Jain, Jun Gu, Rashmi Kanagal-Shamanna, et al.
Cancers
|
December 10, 2021
Integrated Clinical Genotype-Phenotype Characteristics of Blastic Plasmacytoid Dendritic Cell Neoplasm
C Cameron Yin, Naveen Pemmaraju, M James You, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
|
October 15, 2016
P53 expression correlates with poorer survival and augments the negative prognostic effect of MYC rearrangement, expression or concurrent MYC/BCL2 expression in diffuse large B-cell lymphoma
Xuan J Wang, L Jeffrey Medeiros, Carlos E Bueso-Ramos, et al.
American Journal of Clinical Pathology
|
May 27, 2024
Integrative immunophenotypic and genetic characterization of acute myeloid leukemia with CBFB rearrangement
Fnu Sameeta, Sa A Wang, Zhenya Tang, et al.
American Journal of Hematology
|
March 5, 2024
Myeloid neoplasm with <10% blasts and t(3;5)(q25.1;q34)/NPM::MLF1: A classification dilemma
Fnu Sameeta, Hong Fang, Wei Wang, et al.
Cancers
|
December 9, 2023
Cytogenetic Profile in Monoclonal Gammopathy of Undetermined Significance, Smoldering and Symptomatic Multiple Myeloma: A Study of 1087 Patients with Highly Purified Plasma Cells
Guilin Tang, Yilin Wu, Pei Lin, et al.
Journal of Neuropathology and Experimental Neurology
|
September 13, 2024
Epithelioid angiosarcoma arising from pleomorphic xanthoastrocytoma, CNS WHO grade 3
Austin J Helmink, Kanish Mirchia, Frank M Mezzacappa, et al.
Page
of 14